GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortrea Holdings Inc (FRA:K67) » Definitions » Other Current Receivables

Fortrea Holdings (FRA:K67) Other Current Receivables : €507 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Fortrea Holdings Other Current Receivables?

Fortrea Holdings's Other Current Receivables for the quarter that ended in Mar. 2024 was €507 Mil.

Fortrea Holdings's quarterly Other Current Receivables increased from Sep. 2023 (€541.96 Mil) to Dec. 2023 (€543.87 Mil) but then stayed the same from Dec. 2023 (€543.87 Mil) to Mar. 2024 (€507.01 Mil).

Fortrea Holdings's annual Other Current Receivables increased from Dec. 2021 (€466.66 Mil) to Dec. 2022 (€568.48 Mil) but then declined from Dec. 2022 (€568.48 Mil) to Dec. 2023 (€543.87 Mil).

Fortrea Holdings Other Current Receivables Historical Data

The historical data trend for Fortrea Holdings's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortrea Holdings Other Current Receivables Chart

Fortrea Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Current Receivables
- 466.66 568.48 543.87

Fortrea Holdings Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 494.46 541.62 541.96 543.87 507.01

Fortrea Holdings Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Fortrea Holdings Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Fortrea Holdings's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Fortrea Holdings (FRA:K67) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortrea Holdings Inc (FRA:K67) » Definitions » Other Current Receivables
Comparable Companies
ZLAB MLTX DNLI BHVN MDGL NTLA ARWR RVMD IBRX DNA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
FTRE:USA FTRE1:Mexico
Address
8 Moore Drive, Durham, NC, USA, 27709
Website
https://www.fortrea.com
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Fortrea Holdings (FRA:K67) Headlines

No Headlines